Review
The dermorphin peptide family

https://doi.org/10.1016/0306-3623(95)02149-3Get rights and content

Abstract

  • 1.

    1. In 1980, the skin of certain frogs belonging to the genus Phyllomedusinae was found to contain two new peptides that proved to be selective μ-opioid agonists. Given the name dermorphins, these were the first members of a peptide family that in the past 15 years has grown to reach a total of seven naturally occurring peptides and nearly 30 synthetic analogs.

  • 2.

    2. Dermorphin peptides are potent analgesics in rodents and primates, including man. Some dermorphins can enter the blood-brain barrier and produce central antinociception after peripheral administration.

  • 3.

    3. The dermorphin family also includes μ1-opioid receptor selective agonists that produce intense opioid analgesia, but stimulate pulmonary ventilation.

  • 4.

    4. Experiments in rats and mice chronically exposed to dermorphins have shown that not only do they have higher antinociceptive efficacy and potency than morphine, but they are also less likely than morphine to produce tolerance, dependence and opiate side effects.

References (95)

  • V. Erspamer

    The opioid peptides of the amphibian skin

    Int. J. Devel. Neurosc.

    (1992)
  • V. Erspamer

    Bioactive secretions of the Amphibian integument

  • G. Feurestein et al.

    Central autonomic effect of dermorphin in conscious rats

    J. Pharmac. Exp. Ther.

    (1983)
  • D. Giudici et al.

    Dermorphin stimulates prolactin secretion in the rat

    Neuroendocrinol.

    (1984)
  • G Improta et al.

    Neural regulation of gastric acid secretion in rats: influence of dermorphin

    Regul. Peptides

    (1982)
  • G. Improta et al.

    The role of caudate nucleus in dermorphin-induced catalepsy in rats

    Peptides

    (1985)
  • L. Intorre et al.

    The role of peripheral opioid receptor subtypes in the modulation of gastric acid secretion and plasma gastrin in dogs

    Eur. J. Pharmac.

    (1993)
  • L.S. Jones et al.

    Dermorphin-induced hyperexcitability in hippocampal CA3 and CA1 “in vitro”

    Eur.J. Pharmac.

    (1994)
  • D.R. Kapusta et al.

    Central μ-opioid receptor mediated changes in renal-function in conscious rats

    J. Pharmac. Exp. Ther.

    (1993)
  • L.H. Lazarus et al.

    The toad, ugly and venomous, wears yet a precious jewel in his skin

    Progress Neurobiol.

    (1993)
  • E. Lezoche et al.

    Effect of dermorphin, a new opiate-like peptide, on gastric secretion, exocrine pancreatic secretion and gall bladder motility in man

    Regul. Peptides

    (1983)
  • P. Melchiorri et al.

    Structure-activity relationships of the delta-opioid selective agonists, deltorphins

    Eur. J. Pharmac.

    (1991)
  • M.E. Meyer et al.

    DALDA (H-Tyr-D-Arg-Phe-Lys-NH2), a potent μ-opioid peptide agonist, affects various patterns of locomotor activities

    Pharmac. Biochem. Behav.

    (1995)
  • G. Mignogna et al.

    Identification and characterization of two dermorphins from skin extracts of the Amazonian frog Phyllomedusa bi-color

    FEBS

    (1992)
  • T. Mitsuma et al.

    Dermorphin inhibits basal and cold-induced thyrotropin secretion in rats

    Endocrin. Exper.

    (1985)
  • A. Mor et al.

    Identification of a D-Ala-containing polypeptide precursor for the peptide opioid, dermorphin

    J. Biol. Chem.

    (1991)
  • A. Mor et al.

    Evidence for pro-dermorphin processing products in rat tissues

    Biochem. Biophys. Res. Commun.

    (1990)
  • H.I. Mosberg et al.

    Dermorphin-like tetrapeptides with δ-opioid receptor activity. 3. Effect of residue 3 modidfication on “in vitro” opioid activity

    Mol. Pharmac.

    (1990)
  • G. Nisticò et al.

    Comparative effcts of β-endorphin and dermorphin on behaviour, electrocortical activity and spectrum power in chicks after intraventricular administration

    Res. Commun. Physiol. Psychiat. Behaviour

    (1981)
  • P. Paakkari et al.

    Respiratory mu-opioid and benzodiazepine interactions in the unrestrained rat

    Neuropharmacology

    (1993)
  • P. Paakkari et al.

    Respiratory and locomotor stimulation by low doses of dermorphin, a mu1 receptor-mediated effect

    J. Pharmac. Exp. Ther.

    (1990)
  • K. Richter et al.

    D-Alanine in the frog skin peptide dermorphin is derived from L-Alanine in the precursors

    Science

    (1987)
  • S. Sakurada et al.

    Antinociceptive mechanism of [D-Arg2]dermorphin tripeptide analogs

    J. Pharmac. Exp. Ther.

    (1992)
  • G.E. Sander et al.

    Enkephalin analogs and dermorphin in the conscious dog: structure-activity relationships

    Peptides

    (1982)
  • G. Sandrini et al.

    Dermorphin inhibits spinal nociceptive flexion reflex in humans

    Brain Res.

    (1986)
  • T. Sato et al.

    Opioid activities of D-Arg substituted tetrapeptides

    J. Pharmac. Exp. Ther.

    (1987)
  • P.W. Schiller et al.

    Dermorphin analogues carrying an increased positive net charge in their “message” domain display extremely high μ-opioid receptor selectivity

    J. Med. Chem.

    (1989)
  • C.K. Surrat et al.

    μ Opiate receptor. Charged transmembrane domain amino acids are critical for agonist recognition and intrinsic activity

    J. Biol. Chem.

    (1994)
  • J.B. Wang et al.

    μ opiate receptor: cDNA cloning and expression

  • F. Aloisi et al.

    Central effects of dermorphin

    Ann. Istituto Sup. Sanità

    (1982)
  • A. Ambo et al.

    Synthesis of carboxy-terminal extension analogs of dermorphin and evaluation of their opioid receptor binding and opioid activities

    Chem. Pharmac. Bull.

    (1994)
  • M. Baldieri Linari et al.

    The effect of dermorphin on exocrine pancreatic secretion of the rat

    Ital. J. Gastroenterol.

    (1983)
  • W.A. Banks et al.

    Peptide transport systems for opiates across the blood-brain barrier

    Am. J. Physiol.

    (1990)
  • M. Broccardo

    Development of tolerance to the effect of dermorphin on gastric emptying in the rat

    Pharmac. Res. Commun.

    (1985)
  • M. Broccardo et al.

    Cross-tolerance between dermorphin and morphine to analgesia and catalepsy in rats

    Peptides

    (1985)
  • K. Chaki et al.

    Antinociception and physical dependence produced by [D-Arg2]dermorphin tetrapeptide analogs and morphine in rats

    Br. J. Pharmac.

    (1988)
  • K. Chaki et al.

    Comparison of the antinociceptive effects of new [D-Arg2]dermorphin tetrapeptide analogs and morphine in mice

    Pharmac. Biochem. Behav.

    (1988)
  • Cited by (84)

    • Cardiorespiratory action of opioid/tachykinin agonist peptide hybrid in anaesthetized rats: Transduction pathways

      2017, European Journal of Pharmacology
      Citation Excerpt :

      It strays from stereotyped cardiac response of the baroreflex, coexistent with reduced blood pressure (Helke and Seagard, 2004). Either of the two pharmacophores was reported to induce bradycardia in rats (Eager et al., 1994; Melchiori and Negri, 1996; Portolano et al., 1991; Wojciechowski et al., 2016). The lack of this downward trend might be possibly attributed to that AWL3106 is a new molecule of different pharmacodynamic properties, compared with the rudimental pharmacophores.

    • Opioid and Bv8 Peptides

      2013, Handbook of Biologically Active Peptides
    • Gene expression analysis by ESTs sequencing of the Brazilian frog Phyllomedusa nordestina skin glands

      2013, Toxicon
      Citation Excerpt :

      In spite of the substitution of the non-polar amino acid residue (Phe) for a polar one (Ser), no change in the partial charge of the peptide could be detected (data not shown). Besides this amino acid substitution, all peptides encoded by both contigs have a C-terminal portion that is liable to amidation, which increases the peptide affinity for the receptor (Melchiori and Negri, 1996). But there is no clear indicative that the amino acid substitution observed here influence the biological activity of the peptide encoded by DM01 contig.

    View all citing articles on Scopus
    View full text